Synapse - Genitourinary Oncology Service

Results (123)

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer and BRCA1/2 gene alterations: Final analysis from the randomized phase 3 MAGNITUDE trial

Journal Article

Rathkopf, D. E.; Roubaud, G.; Chi, K. N.; Efstathiou, E.; Attard, G.; Olmos, D.; Small, E. J.; Saad, M.; Castro, E.; Kim, W.; more...
European Urology (2025)

Fulltext@MSK | Save

Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma

Journal Article

Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
European Urology (2025)

Fulltext@MSK | Save

Bladder preservation strategies in muscle-invasive bladder cancer: Recommendations from the International Bladder Cancer Group

Review

Gupta, S.; Hensley, P. J.; Li, R.; Choudhury, A.; Daneshmand, S.; Faltas, B. M.; Flaig, T. W.; Grass, G. D.; Grivas, P.; Hansel, D. E.; more...
European Urology (2025)

Fulltext@MSK | Save

First-line pembrolizumab plus lenvatinib for advanced non–clear-cell renal cell carcinoma: Updated results from the phase 2 KEYNOTE-B61 trial

Journal Article

Voss, M. H.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthélémy, P.; Lee, J. L.; Nalbandian, T.; more...
European Urology (2025)

Fulltext@MSK | Save

Epidemiology and risk factors for testicular cancer: A systematic review

Review

Tateo, V.; Thompson, Z. J.; Gilbert, S. M.; Cortessis, V. K.; Daneshmand, S.; Masterson, T. A.; Feldman, D. R.; Pierorazio, P. M.; Prakash, G.; Heidenreich, A.; more...
European Urology (2025)

Fulltext@MSK | Save

Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma

Journal Article

Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
European Urology (2025)

Fulltext@MSK | Save

Refining risk stratification of high-risk and locoregional prostate cancer: A pooled analysis of randomized trials

Journal Article

Ravi, P.; Xie, W.; Buyse, M.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Attard, G.; Clarke, N.; D'Amico, A.; Dignam, J.; more...
European Urology (2025)

Fulltext@MSK | Save

First and second-line treatments in metastatic renal cell carcinoma

Review

Barragan-Carrillo, R.; Saad, E.; Saliby, R. M.; Sun, M.; Albiges, L.; Bex, A.; Heng, D.; Mejean, A.; Motzer, R. J.; Plimack, E. R.; more...
European Urology (2025)

Fulltext@MSK | Save

Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Journal Article

Gillessen, S.; Turco, F.; Davis, I. D.; Efstathiou, J. A.; Fizazi, K.; James, N. D.; Shore, N.; Small, E.; Smith, M.; Sweeney, C. J.; more...
European Urology (2025)

Fulltext@MSK | Save

Intensification approaches and treatment sequencing in metastatic castration-resistant prostate cancer: A systematic review

Review

Francini, E.; Agarwal, N.; Castro, E.; Cheng, H. H.; Chi, K. N.; Clarke, N.; Mateo, J.; Rathkopf, D.; Saad, F.; Tombal, B.
European Urology (2025)

Fulltext@MSK | Save